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Background: The extent to which patients follow treatments as prescribed is pivotal to treatment success. An
exceptionally high level (> 95%) of HIV medication adherence is required to suppress viral replication and protect
the immune system and a similarly high level (> 80%) of adherence has also been suggested in order to benefit
from prescribed exercise programmes. However, in clinical practice, adherence to both often falls below the
desirable level. This project aims to investigate a wide range of psychological and personality factors that may lead
to adherence/non-adherence to medical treatment and exercise programmes.
Methods: HIV positive patients who are referred to the physiotherapist-led 10-week exercise programme as part of
the standard care are continuously recruited. Data on social cognitive variables (attitude, intention, subjective
norms, self-efficacy, and outcome beliefs) about the goal and specific behaviours, selected personality factors,
perceived quality of life, physical activity, self-reported adherence and physical assessment are collected at baseline,
at the end of the exercise programme and again 3 months later. The project incorporates objective measures of
both exercise (attendance log and improvement in physical measures such as improved fitness level, weight loss,
improved circumferential anthropometric measures) and medication adherence (verified by non-invasive hair
analysis).
Discussion: The novelty of this project comes from two key aspects, complemented with objective information on
exercise and medication adherence. The project assesses beliefs about both the underlying goal such as following
prescribed treatment; and about the specific behaviours such as undertaking the exercise or taking the medication,
using both implicit and explicit assessments of patients’ beliefs and attitudes. We predict that i) the way people
think about the underlying goal of their treatments explains medication and exercise behaviours over and above
the effects of the behaviour-specific thinking and ii) the relationship between adherence to exercise and to medical
treatment is stronger among those with more favourable views about the goal. Results from this study should
identify the key contributing factors to inform subsequent adherence research and afford a more streamlined
assessment matrix. The project also aims to inform patient care practices.
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In the last two decades, owing to the advanced treat-
ment, the long term outlook for HIV-positive patients
has considerably improved and now reached 2/3 of the
normal life-expectancy at age 20 with medication [1].
The escalating costs of HIV treatment underscore the
importance of efficiency in HIV treatment. In addition
to the constantly improving medical treatment regime,
quality of life of HIV-positive patients has received
increased attention. Exercise has been one of the most
popular self-care therapies affording many health bene-
fits and improved well-being, assuming low attrition. A
body of literature has assessed the beneficial effects of
exercise adherence in clinical trials [2-6] but not in
home-based intervention [7]. One plausible explanation
is that clinical trial studies typically use highly motivated
volunteers where adherence is automatically assumed
and met. In real life, adherence to exercise and to med-
ical treatment may fall well below desired levels and hin-
der the effectiveness of such programmes [8].
Exercise is known to be a beneficial auxiliary treatment
in many chronic conditions [9]. Studies investigating ad-
herence to exercise in self-managed settings have fo-
cused on conditions such as heart failure, injury,
rheumatoid arthritis, low back pain or cystic fibrosis
[10-12]. Despite the fact that adherence has been iden-
tified as a major barrier to benefits from exercise-based
treatments [13,14], research among HIV patients are
generally focussed on adherence to medications. The
number of studies reporting the influence of adherence
to exercise among HIV patients is limited. Contrary to
published controlled trials showing the positive effect
of exercise and reports which indicate that 25% of
HIV patients failed to meet daily recommended phys-
ical activity guidelines [15,16], an observational study
suggested that adherence in the clinical setting is ra-
ther low with only half of the referred patients choos-
ing to participate and adhere to the prescribed and
physiotherapist-led exercise programme [17]. Apart
from the missed benefits from exercise, Kyser et al [18]
also found that patients who did not engage in any
aerobic exercise in the last 30 days were more likely to
be non-adherent to medication.
To date, there is a hiatus in studies investigating the
psychosocial determinant of adherence and non-
adherence to physiotherapist-led exercise programmes
in HIV patients, or exploring the relationship and mod-
erating factors between adherence to medical treatment
and prescribed exercise. Furthermore, the relationship
between cognitive factors of adherence to medical treat-
ment regimes and exercise has not been investigated.
Understanding factors that influence volitional behav-
iour has been in the centre of adherence research. Gen-
erally, HIV patients indicate a strong intention to taketheir medications as prescribed, but despite this their
observed or self-reported adherence often falls below the
optimal level [19]. In relation to adherence to treatment
regimes among HIV patients, Munro et al [20] reviewed
6 behavioural models applied to promoting adherence in
a limited number of studies but found little evidence for
effectiveness. Studies in the last 5 years appear to be re-
iterating the same conclusion with some finding the
Theory of Planned Behaviour (TPB) [21] instrumental to
enhance adherence [22] whereas others found that only
a small fraction of the variance in intention to adhere to
antiretroviral therapy was explained by the classic TPB
predictor set of attitude, norms and perceived control
[23]. Self-regulatory processes were found to mediate be-
tween intention and adherence [24]. Furthermore, out-
come beliefs about the medication have been found to
be an important factor in determining adherence
[25,26].
Attempts have been made in the past to identify ‘high-
risk’ patients for non-adherence, relying on relatively
stable predictors such as personality or using predictors
that are beyond the patients’ control, such as barriers to
care or medication, complexity of treatment, costs of
medication or required co-payment [27,28]. In fact, in
HIV positive individuals the motivating and deterring
factors for adherence to medical treatment yield a rather
complex picture [29]. As in most self-regulated behav-
iour, personality characteristics influence the self-
regulatory process in HIV adherence. Adherent patients
are characterised by feeling in control, are empowered
and showing proactiveness, as opposed to non-adherent
patients’ perception of being a ‘victim’ of the HIV treat-
ment regime, passiveness and disempowerment [30]. In
clinical practice, low self-efficacy or depression has been
thought to be related to non-adherence to medical treat-
ment and/or rehabilitation [31-35]. Adherent patients
perceived their quality of life to be higher [36] which is
in line with previous findings showing that those with
better well-being are more likely to show interest in fur-
ther improvements [37]. The role of socioeconomic fac-
tors in HIV treatment adherence is ambiguous [38] but
gender [39] and ethnic [18,40,41] differences were
observed.
Scientific justification and theoretical framework
The novelty of this project comes from the theoretical
framework applied and the measurements utilised in
data collection. From the theoretical point of view, the
key aspect of the project is that it is assessing cognitions
about both the underlying goal of following prescribed
treatment and about the specific behaviours such as tak-
ing medication as prescribed and exercise (Figure 1).
From the methodological aspects, the novel elements
are the consideration of both implicit and explicit
Figure 1 Conceptual framework of medication and exercise adherence. Light blue arrows represent the behavioural intention pathway
(TPB). Goal intention models: dark blue arrows denote a pathway where goal intention is an antecedent; dark burgundy arrows show a pathway
where goal intention is a moderator of the behavioural intention.
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exercise (attendance and clinically meaningful improve-
ment in physical measures, such as improved fitness
level, weight loss, improved circumferential anthropo-
metric measures, improved one repetition maximum
strength measures) and medication adherence (hair
analysis).
The TPB, along with other social cognitive models
[42] and specifically in relation to health actions [43],
assumes that any given behaviour is a functional out-
come of the attitude – intention – behaviour sequence,
which makes the model suitable for understanding and
predicting volitional health-preserving or improving
behaviour. The efficacy of the TPB in relation to health-
related behaviour is dependent on the particular behav-
iour (i.e. adhering to health improvement or engaging in
risky activities), age, time-frame and measurements [44].
Improvement made in order to increase the predictive
power of the TPB model is abundant, including descrip-
tive norms [45], subjective norms [46], self-identity [47],
self-efficacy and locus of control [48], behavioural con-
trol [49], anticipated regret [50,51], desires and emotions
[52], moral norms and anticipated affect [53], social cog-
nition properties [54], prototypes and willingness [55],
conscientiousness [56] and goals and its properties [57].
The variations of the augmented TPB models acknowl-
edges the complexity of factors underlying the ultimatebehavioural choice but nevertheless assume that the be-
haviour is predicted by some combination of social cog-
nitive factors about the behaviour. Whilst each added
variable incrementally increases the predictive power of
the TPB model, it inadvertently introduces some unex-
plained variances with each predictor, thus the price to
be paid for the improvement manifests in complexity.
Meta-analyses have shown that beliefs and attitudes in
the TPB model predict 39% of the behavioural intention
and 27% of the actual behavior, with notably stronger
prediction when behavior was based on self-reports [58].
In order to close the gap between behavioural intention
and actual behaviour, Gollwitzer and Sheeran [59] pro-
posed the addition of implementation intention.
Approaching behaviour from a different angle, the
Control Theory [60] proposes that behavioural choices
are driven by goal pursuits, where desired goals induce
intentions but also serves as reference values against
which the progress of achieving the goals are constantly
monitored and adjusted if necessary. The allowance for
incremental approaches to the desired goals connects
goal theories of behaviour [57] and implementation
intentions [59] via self-regulation by which people con-
trol their feelings and impulses to ensure behavioural
outcomes that are perceived to be desirable. Self-
regulation is a complex process that includes long-term
perspectives in constant monitoring attainments [60] as
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long term goals [61]. The self-regulatory effect is
thought to rely on a limited energy resource that can be
temporarily depleted, hence exerting effects on other be-
havioural choices made simultaneously or shortly after
[62].
Investigations of the role of self-regulation in long-
term medication adherence [63] revealed that self-
regulation not only accounted for the largest explained
variance in the self-determination theory-based model
but also was the only variable that showed significant
correlation with both self-reported adherence to pre-
scribed medication and pill-count. Self-managed care
based on a self-regulation framework has been shown to
be effective in health-maintenance among people with
chronic health conditions including improvement in
condition, along with better physical and psychosocial
functioning [64]. Other examples for interventions based
on self-regulation theory being successful are related to
reducing risk of coronary heart disease [65], reducing
depression among people suffering from rheumatoid
arthritis [66] and end-stage renal disease [67].
Self-regulation is present in peoples’ daily lives because
discrepancies between expectations and reality in situa-
tions people encounter are inevitable. Successful adap-
tive functioning is based on effective self-regulation by
which people control their impulses, thoughts, feelings
and adjust their behaviour to close or minimize the gap
between their expectations and present experiences. The
information processing models of self-regulation focuses
on the process of constant comparison and feedback be-
tween the current and the desired, informing the neces-
sary adjustment required to the behaviour [68].
However, the way people carry out this task is a reflec-
tion of their individual dispositions. General personality
dimensions and specific self-referent personality traits
are thought to be inseparably intertwined with self-
regulation [69,70]. General personality dimensions such
as conscientiousness [71], impulsiveness vs. constraint
[72] and specific self-referent traits such as self-efficacy
and self-esteem [73] are key components of the self-
regulative process.
Every step of the self-regulative process, which can
manifest in active initiation and maintenance of a goal-
oriented and effortful activity or inhibition of impulsive
behaviour that could jeopardize reaching the desired
state, is influenced by the personality factors. Individual
differences determine people’s dispositional capacity for
self-regulation, as well as affecting the dynamics of the
regulatory processes [69]. Stable individual differences
determine the self-regulatory strategies individuals auto-
matically employ [74]. Personality traits affect how ambi-
tious the goals are; how discrepancies are viewed; and
what self-regulatory strategies are employed. Personalityalso influences whether people exhibit flexibility in be-
haviour to achieve the desired goal or increase effort in
following the behavioural path they set themselves on,
initially assuming that the discrepancy between the
desired and current state is to be bridged by trying
harder or one is motivated to find alternative ways to
reach the desired goals. Integrating trait and process
variables self-regulation offers a more comprehensive ac-
count of self-regulation [75].
Demographic factors such as gender and age moderate
the effect of personality factors on goal setting, self-
regulation and behavioural antecedents. Although per-
sonality trait changes occur most dominantly in young
adulthood (20-40 years of age), they gradually change at
a very slow pace over the lifespan: self-control generally
increases with age [76-78], along with conscientiousness
[79], self confidence and emotional stability [78]. Gender
differences are small relative to individual variation
within genders and broadly conform with gender stereo-
types of males being more assertive than females who
perceive themselves higher than males on agreeableness,
warmth and neuroticism while being open to feelings,
rather than ideas [80] but no difference exists in impul-
siveness, locus of control or orderliness [81]. Males pos-
sess slightly higher general self-esteem compared to
females [82]. On the contrary, ethnicity within the same
culture does not seem to exert a significant influence on
behaviour but rather culture is seen as aggregate person-
ality profiles [83] that manifest in typical behaviour of
most, but not all, people in a given country [84]. Al-
though cultural differences in broad personality traits
have been consistently shown in cross-cultural studies
[85], within culture differences in personality traits by
ethnicity were found to be generally negligible [86].
The integration of the relevant goal-intention-
behaviour theories is depicted in Figure 1. It shows a
conceptual map that underpins the current investigation
in adherence to prescribed exercise and treatment re-
gime among HIV positive patients. Light blue arrows
show the behavioural intention model based on TPB.
Arrows coloured in dark blue and dark burgundy lay out
the path for the goal intention model, where explicit and
implicit goal intentions are either an antecedent (Goal
intention ! Behavioural intention ! Adherence, shown
in dark blue) or a moderator (Behavioural intention !
Goal intention ! Adherence, shown in dark burgundy)
of the behavioural intention. In the latter case, we expect
the strength of the path between behavioural intention
and adherence being diminished or weakened by the in-
clusion of goal intention between behavioural intention
and adherence [87].
A person’s ability to follow a long-term interest via
self-regulation plays a vital role in medical treatment,
particularly in conditions that require prolonged health
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many segments of self-regulation appear to be in the un-
conscious and automatic domain, health improvement
or maintenance requires conscious, effortful and goal-
oriented self-regulatory behaviour. That is not to say
that unconsciously held motivators do not play an im-
portant role in consciously self-regulated behaviour.
Dual process models [88] suggest the existence of a two-
tier system where the higher-order system is responsible
for reflective and planned behaviour whilst the lower-
order system responds to associative cues at the moment
[89].
Automatic processes occur without intention or
awareness whereas controlled processes are based on
intentional effort to either seek information in order to
choose the appropriate action or to inhibit automatic
processes in order to execute the selected action.
Clearly, implicit automatic and explicitly controlled pro-
cesses are qualitatively different entities that independ-
ently contribute to regulating human behaviour [90,91].
Research in implicit social cognition provides ample evi-
dence that thought processes outside the conscious do-
main influence behaviour and that the processes under
conscious control constitute only a small fraction com-
pared to what is present in decisions about behaviour
[92]. The distinction between automatic implicit and
self-controlled explicit processes has been evidenced in
motivation [93], attitudes, stereotypes, self-esteem and
self-concept [94,95] with considerable individual differ-
ences in awareness of and ability to control automatic
processes [92,96] being evidenced. Despite this, most
policy development narrow-mindedly assumes that be-
havioural choices are exclusively under the controlled
processes when devising preventive measures and inter-
ventions to encourage the desirable behaviour [97]. In
order to improve the effectiveness of such measures, so-
cial policies aiming to behavioural change should incorp-
orate assessment of both implicit and explicit processes
[97].
Therefore for the current project it is proposed that
explicit assessment is complemented with implicit asso-
ciations [98] where appropriate. It is known that indivi-
duals may be biased in how they see themselves and this
bias is often not recognised by the individual [99]. Self-
reported, explicit assessments of individual differences
are particularly prone to distortion, which may or may
not be deliberate. A current research stream in psych-
ology focusing on the uncontrolled, unconscious pro-
cesses [95] provides a promising avenue to compliment
the explicit assessments. Based on the widespread defin-
ition of attitude as a relatively stable tendency to evalu-
ate an attitude object with some degree of like or dislike,
implicit attitudes are defined as associative processes
reflecting this tendency [100]. Associative evaluationsare the result of stimulus driven, uncontrolled, uninten-
tional, goal independent or unconscious processes [101]
and as such, they do not require respondents to be
aware of these attitudes and may be free of self-
presentation distortion in some key cognitions such as
conscienciousness [102]. Recent research has shown that
implicit association adds to the predictive power of ex-
plicit attitude measures [103] via one of eight possible
mechanisms [104]. Based on the assumption that impli-
cit associations either predict or moderate the relation-
ship between antecedents and actual behaviour, Implicit
Association Tests (IAT) have been applied to understand
consumer behaviour [105-107], job satisfaction among
nurses caring for drug addicts [108], doping behaviour
[109] academic performance [110], suicide attempts
[111,112], addiction [113], dietary change [114], dental
hygene [115] or HIV-risk sexual behaviour [116], illus-
trating the widespread use of the IAT concept. In the
current project, using the Brief IAT (BIAT) concept
[117], implicit measures include self-efficacy, attitude
and norms. Implicit tests use exactly-matched content
to explicit measures ensuring that both explicit and im-
plicit measures are equally and directly related to the
concept [118,119].
With adherence constructs being the vital outcome
measures, it is crucially important to have reliable infor-
mation on them. Whilst exercise adherence can be easily
measured by using the attendance log but adherence to
drug treatment is less straightforward [120]. As an ob-
jective alternative (at least for research purposes), meas-
uring the levels of anti-HIV drugs in patients' hair has
been proposed [121,122]. Methodologies have already
been developed for detecting the presence of nevirapine
[123], efavirenz, lopinavir and ritonavir [124] and lopinavir/
ritonavir and atazanavir in hair [125] using liquid
chromatography coupled with tandem mass spectrom-
etry (LC-MS/MS). In this project, hair analysis is
planned to test for the presence of the key anti-viral
drugs, including new method development for tenofovir
and abacavir in hair, to verify self-reports on adherence
or non-adherence. As indirect outcome measures, clinic-
ally meaningful improvement [126,127] is expected in
fitness, circumference measures and perceived quality of
life.
Research question
Although a high level of adherence is required to benefit
from prescribed medication and exercise programmes,
in clinical practice adherence occurs on a continuum
and often falls below the desirable level. Therefore, the
primary objective of this project is to investigate psycho-
logical and socio-economical factors that may lead to ad-
herence/non-adherence to medical treatment and
exercise programmes, with the view of identifying the
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and subsequent adherence research. In addition, the pro-
ject explores the extent to which explicit and implicit
cognitions about the underlying goal predict variance in
medication and exercise adherence. Specifically, we pre-
dict that cognitions about the underlying goal explain
variance in medication and exercise behaviours and in
the relationship between adherence to both exercise and
adherence to medical treatment over and above the
effects of the behaviour specific cognitions (Figure 1).
The goal intention is an antecedent or a moderator of
the behavioural intention.
Hypothesis
We hypothesise that the way people think about the
underlying goal of their treatments explains medication
and exercise behaviours over and above the effects of
the behaviour-specific thinking. We also predict that the
relationship between adherence to exercise and to med-
ical treatment is stronger among those with more
favourable views about the goal.
Specifically, based on models predicting health behav-
iour, we expect that
1. explicit and implicit cognitions (e.g. attitude,
subjective norms, etc.) about the behaviour predicts
variance in medication and exercise behaviours;
2. explicit and implicit cognitions (e.g. attitude,
subjective norms, etc.) about the underlying goal
explains (predicts variance in) medication and
exercise behaviours over and above the effects of the
behaviour-specific cognitions;
3. personality characteristics have a modifying effect on
these predictions;
4. there is a positive relationship between adherence to
exercise and adherence to medical treatment; and
5. the relationship between the two is stronger among
those with more favourable cognitions about the
goal.
Method
Setting and participants
The study utilises a repeated measure design with base-
line and two follow-up measures (Figure 2). The
physiotherapist-led exercise intervention takes place be-
tween the baseline and the first follow-up measure. The
second follow up measure serves as a checkpoint
whether exercise (in case adherence was good during
the physiotherapist-led weeks) has been maintained, and
if there is any change in the underlying cognitive pro-
cesses of exercise behaviour and goals. The testing pro-
tocols are very similar at T0, T1 and T2 with a minor
modification which only manifests in phrasing the ques-
tion to reflect the actual situation, pre-post treatmentand follow up. Variables of the testing protocol are listed
in the Additional file 1: Variables and measures.
Data are collected among HIV seropositive patients
attending the outpatient clinic at Guy’s and St Thomas’
Hospital London. Willing participants are assessed
according to the set criteria for inclusion and exclusion.
Inclusion criteria are: diagnosed as HIV positive, phys-
ician assessed and referred to the 10 week gym
programme at Guy’s and St Thomas’ Hospital, age be-
tween 18-55 and able to give informed consent. Default
by inclusion, patients who are medically (physically and/
or mentally) unstable are excluded from the study. Fur-
ther exclusion criteria include those who have attended
the programme within the last 3 months; patient with
insufficient knowledge of English language to perform
the computerised test and/or complete the questionnaire
as assessed by the pre-screening questionnaire and in-
ability to provide hair samples owing to lack of hair or
having hair with aggressive chemical treatment such as
bleaching or perming. Patients with cognitive impair-
ment sufficient to limit ability to perform the compu-
terised test and/or complete the questionnaire are also
excluded. Cognitive status is assessed using the Mini
Mental State Examination (MMSE) test with a cut off
score of 27, following the new guideline [128].
Sample size
The target sample size for recruitment is n = 60 to allow
maximum 35% attrition thus reaching the final sample
size of 40 with completed datasets. The total sample size
consists of two qualitatively different groups: those with
good adherence to exercise programme and those with
poor adherence/drop out/nonattendance. Constant effort
is made to create groups with equal sample sizes.
Sample size calculation was based on the results from
a previous study [17]. Finding statistically significant dif-
ference/relationship with medium effect size (d = 0.3) at
alpha error probability = 0.05, 1 beta error probability =
0.8, two tail analysis for the FAHI Quality of Life (QL)
measure [129] between two groups (independent sam-
ple): n = 44 (combined sample); FAHI QL measure
change in the adherent group (repeated measure): n = 10
(combined sample); and fitness index change in the ad-
herent group (repeated measure): n = 74 (combined sam-
ple). The difference in fitness baseline measure between
adherent and non-adherent patients was very small.
Information on effect sizes for other measures is not
yet available. Using the definition of 'clinically meaning-
ful change', we assume medium effect size. However, a
secondary aim of this study is to establish thresholds for
clinically meaningful change in the key outcome vari-
ables (CD4 count, quality of life, fitness and physical
measures). The present study will provide invaluable in-
formation for future studies regarding the minimum
Figure 2 Study design diagram. Screening for eligibility (S1), followed by a baseline (T0) and two repeated measures (T1 & T2).
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change (i.e. + 20 metres in the 6-minute walk test, + 0.5
SD achieved on the FAHI QL questionnaire) and statisti-
cally significant differences.
Recruitment of patients
Eligible participants are continuously recruited by the
physiotherapists at St Thomas' Hospital as they are
identified by their treating physicians as requiring refer-
ral to the 10-week exercise programme as part of their
standard care. In addition, posters are placed in waiting
rooms informing patients about the study and calling
for participants. Finally, the research group are actively
involved in disseminating up to date information about
the project at specialised interest group meetings and
conferences.
Data collection
Each eligible participant is tested three times. The ini-
tial assessment is conducted when the patient is re-
ferred to the exercise programme, has volunteered to
participate, and is eligible for the study (T0). The dur-
ation of the physiotherapist-led exercise programme is
10 weeks, comprising of two, 1-hour sessions per
week. Participants are tested again at the end of the
exercise programme (T1) and again in approximately
10-12 weeks (T2) during which time patients are
assumed to maintain their exercise programme indi-
vidually. All participants are asked to attend the test-
ing sessions, regardless of their level of adherence to
exercise. Participants are compensated for their time
by gift vouchers (value of £75.00 in total) after each
session.
The recruitment is staggered and continuous. The
total timeframe for each patient involved in three testing
sessions is 25 weeks, including post testing and allowing
for delays owing to personal circumstances. Each testing
session will last for approximately 90 minutes with short
breaks between the implicit assessment test blocks or asrequired during the completion of the questionnaire and
physical testing. To avoid cognitive fatigue, compu-
terised and paper psychological tests are interspersed be-
tween the elements of the physical tests.
Participants are asked to donate a hair sample at T2.
The hair sample (a diameter of 3 to 4 mms, approxi-
mately 50 hairs), 3-4 cm in length and preferably un-
treated is taken by the attending physiotherapist
cutting near the skin surface using a pair of blunt edge
scissors in appropriate privacy to observe local patient
dignity standards. Depending on hairstyle, if possible,
cuts are taken from different locations of the head to
avoid bald patches. Hair samples are catalogued by the
ID code and stored in a paper envelope tested for the
presence of selected Combination Antiretroviral Ther-
apy (cART) drugs and used to verify adherence to
medical treatment.
Data on individual patients’ medical record, physical
assessment, attendance, psychological tests and hair
sampling are linked via numerical codes. Coding is
undertaken by the physiotherapy researchers. Other
researchers in this project only have access to the coded
(hence anonymous) data set. Data collection and analysis
are completely separated to negate any researcher bias.
Owing to the staggered start-finish of the data collection,
the full dataset is not analysed until the data collection
is complete.
To meet the objectives, this project is designed to
screen a wide range of variables that may contribute
to adherence/non-adherence to medical treatment and
exercise programmes in HIV positive patients with
the view of selecting key variables and establishing
testing protocols to inform a subsequent, large scale
investigation/intervention study. These variables can
be categorised as i) input variables: physical assessment,
psychological assessment, medical information, demo-
graphics; and ii) outcome variables: adherence to treat-
ment, verified by objective information (drug analysis and
attendance log).
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A male patient from the exercise programme was
involved in reviewing the research protocol, Information
sheet for Participants, and Consent form. He provided
valuable feedback to the research team and amendments
were made throughout to incorporate his comments.
The computerised psychological assessment and self-
report questionnaire was also tested with two volunteers
prior to the data collection. Volunteers were asked to
complete the test in the presence of the physiotherapist
and 'think loud' (i.e. voicing their thought processes).
Data collected during this exercise are excluded from
the final dataset. The main goal of this exercise was to fi-
nalise a testing protocol and the data recording system
with as little ambiguity as possible. Patients whom
assisted the research in these capacities are excluded
from the study.
Variables
Variables for this study were selected from a wide range
of factors known from previous research to influence
adherence. To capture reasons for adherence/non-
adherence beyond verbal declarations, parallel measures
of explicit cognitions with implicit associations is planned.
This approach will allow us to capture cognitions in
situations where participants are i) unaware of what
is being measured or ii) have no conscious access to
the assessed property or iii) have no control over the
measurement outcome. Hair analysis is proposed as
an objective measure of adherence and is used to verify
self-declared adherence.Figure 3 Setup of the Brief Implicit Association Tests. Implicit measure
behaviours.Implicit associations
Implicit measures of attitude, self-efficacy and intention
are modified from the BIAT [117]. The BIAT consists of
2 trial blocks with 4 categories, 4 exemplars in each.
Contrary to the classic IAT, the BIAT only focuses on 2
of each block’s 4 categories.
For the purpose of this project, the BIAT has been
adapted to adherence to i) exercise and ii) medical
treatment. Adherence is defined as completing all ses-
sions and taking all medication as prescribed. The ad-
herence category (expressed as frequency) is combined
with i) attitude, ii) self-efficacy and iii) behavioural
intention measures (Figure 3). Each of the nine tests
consists of 48 trials in 2 blocks where each block con-
tains 24 trials (8 practice followed by 16 trials). Order
of the blocks within each test is counterbalanced; order
of the target and the order of the tests are randomised
with a short break between every set of 3 IATs, inter-
spersed with physical assessments. Stimuli for the 9
tests are presented in Table 1, each appearing 4 times
in the trials and each appearing twice for the 8 prac-
tice trials. Text in italics indicates the non-focal cat-
egory. The instructions for each test are presented in
Table 2.
The implicit assessment tests are custom made and
programmed under Linux operation system on a laptop
computer (Samsung P500, Intel Core 2 duo, 15.4"
WXGA screen and full size QWERTY keyboard with in-
dividually mounted keys). For security reasons and to
prevent interference, all other software has been
removed from the laptop.s of attitude, self-efficacy and intention toward the goal and two
Table 1 Stimuli of the adapted Brief Implicit Association Tests (italics denote the non-focal category)
Category Stimuli
Target Goal Following each of my doctor’s orders all, every, entire, total
Not following each of my doctor’s orders none, few, nil, never
Behaviour Attending each of my exercise sessions all, every, entire, total
Not attending each of my exercise sessions none, few, nil, never
Behaviour Taking each of my medications all, every, entire, total
Not taking each of my medications none, few, nil, never
Attribute Attitude (+) Good worthwhile, important, pleasant, nice
(-) Bad pointless, unimportant, unpleasant, nasty
Self-efficacy (+) I can do easy, undemanding, simple, childsplay
(-) I cannot do difficult, demanding, hard, tricky
Intention (+) I intend to planned, expected, wanted, decided
(-) I have no intention unplanned, unexpected, unwanted, undecided
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Explicit measures of attitude contained the exact phrases
used in the IAT as stimuli and rated on a 6-point Likert-
type scale. Statements for the goal attitudes “Following
each of my doctor’s orders is”, medication adherence
“Taking each of my medication is. . .” and “Attending
each of my exercise sessions is. . .” are followed by worth-
while/important/pleasant/nice/unimportant/pointless/
nasty/unpleasant”, giving 3 sets of 8 statements.
Reversed scoring is used for statements containing
‘negative’ words.
Perceived quality of life and overall health in the
screening questionnaire were captured by the answers to
the questions “Would you say your overall quality of life
is. . .” and ‘’Would you say your overall health is. . .” on a
7-point scale ranging from excellent through very good,
good, fair, poor, very poor to unbearable. The single
question self-assessment is based on a previous study
demonstrating that a single question self assessment
regarding one’s health is a reliable indicator of the gen-
eral health [130].
Quality of life was assessed in using the revised Func-
tional Assessment of Human Immunodeficiency Virus
Infection (FAHI) quality of life instrument [129], meas-
uring 5 facets of well-being: physical (13 items), emo-
tional and living with HIV (10 items), functional and
global (13 items), social (8 items) and cognitive function-
ing (6 items).
Validated scales are used to assess conscientiousness
[71], need for cognition [131] and social desirability
[132]. Activity level during the study is self-reported atTable 2 Instructions for the modified Brief Implicit Associatio
Block Instruction for focal key
1 Press ‘I’ for focal concept 1 OR (+) words
2 Press ‘I’ for focal concept 2 OR (+) wordseach measurement point using the International Physical
Activity Questionnaire [133].
The strength of the combination of motivational forces
influencing a behaviour in question is captured in behav-
ioural intention [21], accounting some 30 percent of the
variances in behaviour [134]. The questions assessing
HIV treatment related intentions are “I will follow each
of my doctor’s orders”, “I will take each of my HIV medi-
cations” and “I will attend each of my exercise sessions /
I will continue with exercise” for goal intention and be-
havioural intentions to be adherent to medication and
exercise regimes, respectively.
Subjective norms are assessed with three questions:
“People who are important to me think that I should..” i)
“follow doctor’s prescription” (goal), ii) “take all my HIV
medications” (adherence to medication) and iii) “attend
for every exercise session / continue with exercise” (adher-
ence to exercise).
Anticipated regret about non-adherence toward medi-
cation and exercise are measured with a single statement
each, rated on a 6-point Likert-type scale: “If I did not
take my prescribed medication, I would feel regretful”
and “If I did not do my prescribed exercises, I would
regret”.
Self efficacy beliefs were measured with three state-
ments rated on a 6-point scale ranging from defin-
itely no to definitely yes. The statements started with
“I am confident that. . .” and followed by “I could take
each of my HIV medications”, “I will be able to man-
age my illness”, and “I can continue with my
exercise”.n Tests
Instruction for non-focal key
Press ‘E’ for anything else [focal concept 2 OR (-) words]
Press ‘E’ for anything else [focal concept 1 OR (-) words]
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answered on the 5-point scale ranging between not sure
at all and very sure. All questions are preceded by ”How
sure are you that. . .” with medication and exercise being
asked separately. The questions are: “the medication/
exercise will have positive effect on your health”, “the
exercise will make you feel better”, “taking your medication
as prescribed is necessary to manage your illness to expand
your life”, “doing the prescribed exercises will have a long-
term benefit on your health and quality of life”, “if you do
not take your medication exactly as instructed, your illness
will get worse”.
Self-reported adherence to medication was assessed by
a direct question “When was the last time you missed
taking any of your medication?”, with closed answer
options of “within the past week”, “1-2 weeks ago”, “2-
4 weeks ago”, “1-2 months ago”, “more than 2 months
ago” and “never skip medication”.
Reasons for non-adherence, if present, to medication
and exercise were investigated using the ACTG Baseline
Questionnaire [135], with the questionnaire adapted to
adherence to exercise as well. Exercise non-adherence
related reasons were informed by the informal feedback
patients offered to the physiotherapist in the preceding
years prior to this study. Data from the exercise non-
adherence questions will be tested to ascertain if they
form a valid and reliable scale measuring barriers toward
exercise adherence in this special population, and the
scale will be further developed if promising scale proper-
ties are detected in the present sample. The items are
presented in Additional file 2: Reasons for non-
adherence.
The questionnaires used at the three measurement
points are identical apart from minor modification to
phrasing the question in order to reflect the actual situ-
ation. For example, “attending each of my exercise ses-
sion” in T1 are replaced by “continue with my exercise”
in T2 and T3.
Objective measures
The project incorporates objective measures of both ex-
ercise and medication adherence. Exercise adherence is
assessed via attendance logs during the first phase and
self-managed exercise diary during the second phase.
Clinically meaningful improvement in fitness and phys-
ical indicators (i.e. improved fitness level, weight loss,
improved circumferential anthropometric measures) also
serve as a proxy measure for adherence.
Medical adherence is assessed via self-reports corro-
borated by non-invasive hair analysis, using 50 mg of
cut hair samples. Methods are being developed in house
for two HIV drugs, tenofovir and abacavir, as one of the
two presents in all treatment combination for this
sample. The two drugs are quantified using LiquidChromatography-Tandem Mass Spectrometry (LC-MS/
MS) following extraction from the hair samples. Owing
to the limitations of the method, hair analysis provides
a crude estimation of adherence and thus is mainly
used to flag up individuals with total absence of the
drug in their hair. Quantified drug results in hair are
compared to the anonymised information on medical
treatment.Statistical analysis
Treating missing data will be decided upon examining
the pattern (if any) of the missing data. A missing value
may be replaced if necessary, using the average of the
closest 4 neighbours (two below and two above), ranking
participants by the most similar measure as indicated by
the highest correlation between the two measures. Scale
reliability is tested by calculating internal consistency
coefficients (Cronbach alphas or in case of dichotomous
answer mode, Kuder-Richardson formula). Implicit asso-
ciation reliability is calculated using the split-half
method. IAT effect is calculated as the difference in
average response times between the two focal test
blocks, and individually divided by the variance to derive
the D-scores [136,137]. To identify factors influencing
adherence/non-adherence, discriminant function ana-
lysis are used. Using exercise adherence as a continuous
measure (frequency from the attendance log) will also
allow investigating factors that explain the variance in
adherence the most. The relationship between the two
types of adherence is tested using chi-square analysis,
whereas correlation is used to test relationship between
variables measured on a continuous scale. Building upon
strong correlations, the adherent/non-adherent behav-
iour can also be represented by drawing and testing a
structural equation model. Standard statistical analysis
will be performed using SPSS 19.0, SAS 8.0 and R soft-
ware packages. Behavioural models will be tested with
structural equation modelling, using AMOS 6.0.
Achieved statistical power will be estimated with
G*Power 3.0.1 [138].Project management
Quality control
Owing to the relatively high cognitive demand of the re-
search protocol (series of IATs and a long question-
naire), volunteering participants are assessed for the
cognitive ability and level of English to ensure high qual-
ity data. Recruitment is conducted via the standard care
to create a 'real life' scenario and avoid motivation bias
by recruiting volunteers. The study is designed to inves-
tigate the reasons for adherence and non-adherence in
every day clinical settings, where the research compo-
nent is limited to the psychosocial information which is
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patients.
Compliance
Participation in the study is entirely voluntary and inde-
pendent of their participation of the prescribed exercise
programme. All participants are asked to attend the
three testing sessions, regardless of their level of adher-
ence to the exercise programme. A £20 shopping vou-
cher (redeemable at a major supermarket) is offered for
attending each of the first two testing sessions followed
by a £35 shopping voucher for attending the third test-
ing session, subject to attending the previous two.
Data storage and confidentiality
Confidentiality is maintained throughout the study. Phy-
siotherapists’ access to personal and medical information
is within the remit of standard care and performs the
coding for the research data. Researchers outside the
Hospital do not have access to personal information and
they will receive the data in anonymous (coded) format.
All participants are allocated a subject number upon
signing consent. All data collected from that point on-
wards are defined by subject number only. Data col-
lected are seen by the physiotherapists and used by the
research team in coded, anonymised form. Clinical infor-
mation is incorporated into the final data set by the phy-
siotherapists. Researchers outside the NHS do not have
access to any identifiable information. All data are
recorded in secure CRFs. Any hard copies and tissue
samples (hair) are stored in a locked fire-proof cabinet.
Personal data beyond that stored in the NHS system are
not collected. Any identifiable and personal data are only
accessed by the standard care providers at the Trust. All
data are protected and confidentiality maintained follow-
ing the NHS Code of Confidentiality [139].
The laptop computer used for the computerised test-
ing is encrypted and password protected. The implicit
assessment tests are custom made and programmed
under Linux operation system with no commercially
available programmes on the laptop. The test results are
recorded by the unique ID codes. Hair samples are con-
sidered as ‘gift’ and kept beyond the scope of this project.
It is envisaged that these anonymous samples may be
complemented with samples from other healthy and un-
healthy populations and used in future projects aiming
to assess health. Hair samples collected from living indi-
viduals are exempt from the Human Tissue Act [140].
Research ethics and approval
Owing to the project design and strict inclusion/
exclusion criteria, the project does not raise ethical con-
cerns. Written consent is obtained by the physiotherapists
after providing full study information. Should a participantdecide to withdraw from the study for any reason,
the participant and all identifiable data or tissue collected
would be removed from the study. Data or hair samples
which are not identifiable to the research team may be
retained.
The project has no foreseeable risk to the participants
and their identity is fully protected. The computerised
and self-reported psychological tests are coded by the
attending physiotherapist and although they present a
cognitive challenge, they are completed in segments be-
tween the elements of the physical tests. The physical
assessment and the 10-week exercise programme are
part of the prescribed treatment. None of the physical
tests are to exhaustion.
Involvement in an exercise programme could poten-
tially cause temporary pain, discomfort and/or incon-
venience but it is part of the standard treatment and the
Trust has a generic risk assessment for gym based exer-
cise. In this study, the risks are minimised by prescribing
clinically indicated simple exercises that are suitable for
each participant and that each participant is observed
doing the exercises under the supervision of a state-
registered physiotherapist. Participants may feel inconve-
nienced at attending pre- and post assessment sessions,
however, their time is compensated with gift vouchers.
The research design does not have any risk related to its
activities.
Testing: computerised testing could have potential
acute cognitive fatigue that may affect executive func-
tion in an immediate follow-up task that would also re-
quire executive control. This has no bearing on normal
functioning and should recover within 10 minutes. Al-
though the questionnaire contains some sensitive ques-
tions as part of the standard quality of life assessment
(e.g. satisfaction with sexual life), they will be analysed
collectively at the group level (adherent/non-adherent)
and will not be discussed face to face with the
participant.
The researchers have no conflict of interest. Psycho-
logical testing is added to the exercise programme
provided within standard care. Researchers will have
no direct benefit or detriment from the outcome
of this study. Knowledge generated in this project will
serve future studies into treatment adherence, which
in turn may lead to increased functional capacity and
physical fitness, better heath and improved quality
of life. Although there is no direct benefit to partici-
pants from the research component (psychological
testing), their contribution will lead to a better under-
standing of motivating factors and barriers to adher-
ence and inform future intervention strategies and
support. The level of service provided (standard care)
is not affected whether patients take part or not in
this study.
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tional Research Ethics Service under reference number
09/H0712/86.
Collaboration
The project is a collaborative work between two aca-
demic institutions, Kingston University and The Univer-
sity of Sheffield; and the Guy’s and St Thomas’ NHS
Foundation Trust London.
Discussion
This multidisciplinary project is novel in many ways.
The project assesses beliefs about both the underlying
goal such as following prescribed treatment; and about
the specific behaviours such as exercising or taking the
medication, using both implicit and explicit assessments
of patients’ beliefs and attitudes. In addition, the project
incorporates objective information on adherence to both
exercise and medication. The outcome of this study will
reveal the extent to which patients adhere to treatment
regimens. Psychological assessment results linked to
known non-adherence will provide indicators to identify
patients who are at risk of non-adherence, and may be
used to inform early prevention and intervention
programmes.
The reality of recruiting relatively large numbers of eli-
gible participants into this trial has been a challenge, to
date lasting 2.5 years. Being solely reliant on appropriate
referrals from the wider team initially led to insufficient
through flow of appropriate potential participants. At
approximately 12 months into the recruitment phase,
measures were taken to increase access to suitable can-
didates though to date, the 40 participants required for
the power calculation have not been recruited.
One of the risk elements to the successful research
project has been identified was a possibility that by sign-
ing up for the study itself has an influence on adher-
ence. In addition to the effort made to obtain data from
non-adherent patients to avoid volunteer bias motiv-
ation, attendance records of the project participants are
continuously monitored and compared to the attendance
logs kept since 2002 at the Hospital. Attendance record
of the current nonparticipating patients serves as an an-
chor to compare attendance of the project participants.
Normal business-as-usual gym group clinical activity
has been maintained throughout the trial period, how-
ever some practical issues ensued which are noteworthy.
Firstly self selected attendance rates for trial participants
has led to inconsistent group sizes and subsequent
unpredictable demand on the therapists involved -
particularly when 2 or 3 participants attend for outcome
measures during the same session. Secondly, in reality
we experienced a large variance in the period of time eli-
gible and consenting participants required to completethe computer and paper-based tests and this was skewed
towards longer than expected times. This might be re-
flective of our cognitive and language inclusion criteria
being light in this regard and might inadvertently
impacted on drop-out rates and motivation to return for
outcome measurement sessions. Lastly we expected that
recalling participants for T2 would be problematic with
high risk of drop out. We attempted to mitigate it by
offering the highest proportion of remuneration at this
point of the trial pathway. However despite this T2 out-
comes have constituted a number of non-attendees and
we will analyse this impact.
Our experience so far has shown that inclusion criteria
has meant that approximately 1/3 of gym group patients
with a need for supervised exercise, did not fulfil inclu-
sion criteria for participation in the trial. While we
planned the protocol on real-world patients in reality we
could be subjected to typical trial generalisabilty criti-
cism. Published Health Protection Agency (HPA) data
implicates that there is a clear link between ethnic back-
ground, rate and route of HIV transmission. The major-
ity of people living with HIV in South East London are
either white or black African [141] with an increasing
number of people over the age of 50. See Figure 4 for
characteristics of people living with HIV in South East
London during the trial period. To date, the modest co-
hort in this study is reflective of local prevalence data.
Reasons for exclusion to date are language (n = 11),
cognition (n = 10), age (n = 7) and cART naivety (n = 2).
At the time of writing the mean age of group attendee is
46.5 years (range 19-72 years). Sixteen percent (15/94)
of gym group attendees fell above our 55 years cut off
for the trial. On reflection, the attending physiothera-
pists concede that the views of these patients would have
been as valuable as their younger peers. Should our
study progress to stage 2, we do accept that this should
be considered; changing the upper age limit for recruit-
ment would encompass older adults who are living
longer due to high quality cART as well as those con-
tracting the virus later in life.
One potential confounding factor that has emerged
during data collection is potential mismatch between the
medication records on drug treatment regime and what
patients may actually take, which could easily lead to
categorisation as under-adherent (taking less than
expected) or over-adherent (taking more than expected).
Over-adherence has been observed in relation to other
medications and linked to the number of pills [142,143]
and poor cognition [143], although elsewhere over-
adherence was observed at a higher rate among those
who were on the once-daily regime [144]. A fluctuating
pattern of over- and under-adherence to HAART has
been documented [145], suggesting that adherence to
HAART is not a stable characteristics thus any
Figure 4 Local HPA prevalence data for South East London, average of 2008-2010 [141]. A: ethnic distribution. B: age and gender
distribution.
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study period. Longitudinal study following both medical
and exercise adherence, along with potential reasons for
over-adherence is warranted. Whilst the medical records
provide detailed and accurate information on the drug
treatment regime prescribed to the patient, including
changes over time, these records may not be the exact
reflection of what patients may take. There is a possibil-
ity of a patient having more than one hospital number in
which case there is a temporary mismatch between the
expected and detected drug in patients’ hair samples. In
summary, caution must be used when making inferences
from the observed discrepancies between medical
records and behaviour, as deviation from the medical
records may not automatically indicate fault on the
patient’s side.
Measures to control for a precise matching between
the time periods investigated and length of hair sample
as possible is advisable. One such measure is using axilla
hair and shaving to skin level at baseline to ensure that
previous treatment regime does not have influence on
the results. This however would be likely to make re-
cruitment more challenging as participants have to
accept having a bald patch at the start of the study if
they normally have axilla hair, and conversely, having ax-
illa hair temporarily for those who routinely remove it.
Nevertheless, it could be a feasible alternative to using
scalp hair, axilla hair being less affected by chemical
treatment. Should the project progress to stage 2, weenvisage to create a shorter testing protocol, retaining
only those variables that significantly differentiate be-
tween adherent and non-adherent patients. Additional
factors may be added if results from this study highlight
the need.Additional files
Additional file 1: Variables and measures: Trials_HIV_2012_Additional
file 1.
Additional file 2: Reasons for non-adherence to medication and
exercise: Additional file 2.Trial status
Data collection has started in 2009 and is currently ongoing.
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